![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, November 04, 2006 5:21:15 AM
Firstly: it was mentioned yesterday in the CC.
The general link is:
The third International Congress of the GRS and the IGF society
http://www.congre.co.jp/3grs-igf/
Also the following posts by Biowatchdog and Soulmark52 on Yahoo give more info:
Where is Tercica's booth?
Exhibitors List :
E-1 Pfizer
E-2 Insmed
E-3 Eli Lilly and Company
E-4 Novo Nordisk Pharma
E-5 Serono International
E-6 Dainippon Sumitomo Pharma
Re: Info Coup
That's it, but inside...
The week of November 11 or the next may great us with a bombardment of good news! Fasten your seat belts! This is just a sampling with the relevant new formulation of iPlex and the Cecilia Camacho-Hübner study. I've also thrown in some Clemmon's March info. There are sevral more BP3 study presentations, but I leave that for all of you to read...the first link is the goody. Enjoy!
http://www.congre.co.jp/3grs-igf/images/program.pdf
PO14 IGF Clinical/Therapy
LP-92 Stability of rhIGF-I/rhIGFBP-3 under common storage conditions Kenneth M. Attie Dept. of Medical Affairs, Insmed Inc., Richmond, VA,
USA
OR08-4 The IGFBP-3 partner, humanin, protects beta cells from apoptosis in vitro and improves glucose tolerance in the NOD model in vivo Kuk-Wha Lee Department of Pediatric Endocrinology, Mattel Children's Hospital at University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, USA
OR08-3 Effects of insulin-like growth factor binding protein-3 on human malignant pleural mesothelioma cell growth and apoptosis Cecilia Camacho-Hübner Department of Endocrinology, William Harvey Research Institute and St Bartholomew's Hospital, University of London, London, UK
http://grc.org/programs/2007/insulin.htm
David Clemmons a Lead investigator for Insmed...diabetes
Re: Info Coup
No takers on the OR08-4 presentation?
"IGFBP-3 partner, humanin, protects beta cells from apoptosis in vitro and improves glucose tolerance in the NOD model"
If IGFBP-3 "holds" humanin for delivery...Alzheimer’s
http://www.pepnet.com/humanin.html
Therefore: a lot of interesting news: as you can see the Alzheimer stuff is still in mice tests just like the Herceptin/BP3 Breastcancer tests discussed here a couple of months ago. But again it's a sign of the possibilities INSMEDs product portfolio brings.
Also: nice to see that INSMED is exhibiting between big guns in pharma, it's a recognition of the eminent work done by INSM in the field.
E.
Recent INSM News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/12/2024 08:05:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/12/2024 08:01:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 09:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:00:26 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:00:05 AM
- Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update • PR Newswire (US) • 08/08/2024 11:00:00 AM
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 08/02/2024 12:00:00 PM
- Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024 • PR Newswire (US) • 07/29/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2024 09:19:37 PM
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 07/05/2024 12:00:00 PM
- Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference • PR Newswire (US) • 07/03/2024 01:03:00 PM
- Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025 • PR Newswire (US) • 06/27/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 12:00:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:21:15 PM
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 06/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:23:25 PM
- Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference • PR Newswire (US) • 06/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:00:43 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 08:33:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:46:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:45:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:44:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:41:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 09:32:49 PM
Kona Gold Beverages, Inc. Nears Completion of Reverse Merger with New Candidate • KGKG • Aug 12, 2024 10:00 AM
Maybacks Global Entertainment and DigiTrax Entertainment Sign Agreement to Broadcast "Karaoke Cloud" on iDreamCTV • AHRO • Aug 12, 2024 8:45 AM
HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients • HLYK • Aug 12, 2024 8:00 AM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM